Abiosciences
PrivateLast Round
Series A++
May 25, 2021
Company Overview
Abiosciences operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A++ round in May 2021.
Abiosciences is a biotechnology company that provides single-cell genomic sequencing, bioinformatics analysis, and therapeutic target discovery services for the life sciences and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abiosciences Comparables
Compare Abiosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scailyte AG | 87% | |
| One Biosciences | 83% | |
| Ozette | 80% |
For institutional investors. Book with your work email.
Abiosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | May 25, 2021 | ||||
| Strategic | Feb 1, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Jun 1, 2019 |
For institutional investors. Book with your work email.
Abiosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series A Extension, Series A++, Series A |
| Primavera Venture Partners | Series A++ |
| 松禾资本 (Green Pine Capital Partners) | Series A++ |
| HongShan Capital Group (HSG) | Series A++ |
| SB China Capital | Series A Extension |
| Apricot Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2021
Led by HongShan Capital Group (HSG) with participation from Primavera Venture Partners, IDG Capital, and Green Pine Capital Partners.
For institutional investors. Book with your work email.
Abiosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abiosciences's valuation, stock price, and market status.
Is Abiosciences a public or private company?
Abiosciences is a private company.
What is the current stock price of Abiosciences?
Abiosciences is a private company, so its shares have no public market price. Caplight tracks Abiosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abiosciences worth (valuation)?
Valuation information for Abiosciences is not publicly available.
Can I buy Abiosciences stock?
Abiosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abiosciences's last funding round?
Abiosciences's most recent funding round was Series A++ on May 25, 2021.
Who are the main investors in Abiosciences?
Key investors in Abiosciences include IDG Capital, HongShan Capital Group (HSG), SB China Capital.
Will Abiosciences IPO soon?
No public IPO plans have been announced for Abiosciences.
How can I track Abiosciences secondary market activity?
Caplight tracks bids, offers, and trades in Abiosciences's shares on secondary markets.